Patterns and predictors of dosage increase in patients treated with Adalimumab for Crohn's Disease in the United States

被引：0
|
作者：
Loftus, E., Jr. [1 ]
Pan, X. [2 ]
Zurawski, P. [3 ]
Chao, J. [3 ]
Mulani, P. [3 ]
机构：
[1] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Rochester, NY USA
[2] Univ Iowa, Iowa City, IA USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2009年 / 15卷 / 12期
关键词：
D O I：
10.1097/00054725-200912002-00067
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [1] Adalimumab real-world dosage pattern and predictors of weekly dosing: Patients with Crohn's disease in the United States
    Loftus, Edward V., Jr.
    Pan, Xiaoyun
    Zurawski, Pete
    Mulani, Parvez
    Chao, Jingdong
    [J]. JOURNAL OF CROHNS & COLITIS, 2011, 5 (06): : 550 - 554
  • [2] Dosage Pattern of Adalimumab in Real-World Clinical Practice and Predictors of Dosage Increase in Patients with Crohn's Disease in the US
    Loftus, Edward V.
    Pan, Xiaoyun
    Zurawski, Pete
    Chao, Jingdong
    Mulani, Pervez
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A175 - A176
  • [3] Resolution of flare or nonresponse in patients with Crohn's disease achieved in most adalimumab-treated patients without a dosage increase
    Plevy, Scott
    Schreiber, Stefan
    Colombel, Jean Fred
    Pollack, Paul
    Chao, Jingdong
    Mulani, Parvez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S383 - S384
  • [4] Infliximab dosage increase rate in patients with Crohn's disease
    Plevy, Scott
    Wu, Eric
    Yu, Andrew
    Chao, Jingdong
    Mulani, Parvez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S380 - S380
  • [5] Discontinuation of corticosteroids among Crohn's disease patients treated with vedolizumab in the United States
    Patel, H.
    Chastek, B.
    Null, K. D.
    Demuth, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S350 - S350
  • [6] Benefits of Adalimumab dosage adjustment for patients with Crohn's Disease: An analysis of the CHARM study
    Sandborn, W.
    Colombel, J.
    Rutgeerts, P.
    Pollack, P.
    Chao, J.
    Ps, Mulani
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S29 - S30
  • [7] Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients
    Bultman, E.
    de Haar, C.
    van Liere-Baron, A.
    Verhoog, H.
    West, R. L.
    Kuipers, E. J.
    Zelinkova, Z.
    van der Woude, C. Janneke
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (03) : 335 - 341
  • [8] Duodenal Crohn's disease successfully treated with adalimumab
    Tursi, A.
    [J]. ENDOSCOPY, 2011, 43 : E22 - E22
  • [9] Vaginal Crohn's disease successfully treated with adalimumab
    Kozuch, Patricia L.
    DiMarino, Anthony J.
    Wilson, Kent
    Miller, Cynthia
    Infantolino, Anthony
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S426 - S426
  • [10] Esophageal Crohn's disease treated successfully with adalimumab
    Kwan, Lola Y.
    Conklin, Jeffrey L.
    Papadalkis, Konstantinos A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 639 - 640
12345